BSE Live
Oct 30, 13:50Prev. Close
905.30
Open Price
901.00
Bid Price (Qty.)
895.00 (1)
Offer Price (Qty.)
897.90 (1)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Balance Sheet of Kwality Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 10.38 | 10.38 | 10.38 | 10.38 | 10.38 | |
| Total Share Capital | 10.38 | 10.38 | 10.38 | 10.38 | 10.38 | |
| Reserves and Surplus | 254.67 | 214.77 | 190.85 | 171.38 | 51.33 | |
| Total Reserves and Surplus | 255.47 | 215.57 | 191.65 | 172.18 | 52.13 | |
| Total Shareholders Funds | 265.84 | 225.95 | 202.03 | 182.56 | 62.51 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 15.12 | 19.56 | 27.30 | 20.29 | 18.26 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.41 | 0.27 | 0.00 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 9.18 | 9.18 | |
| Long Term Provisions | 0.25 | 0.22 | 0.90 | 0.75 | 0.68 | |
| Total Non-Current Liabilities | 15.37 | 19.78 | 28.62 | 30.50 | 28.12 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 97.33 | 78.56 | 62.96 | 23.00 | 16.45 | |
| Trade Payables | 55.79 | 44.32 | 35.19 | 34.51 | 26.21 | |
| Other Current Liabilities | 16.22 | 28.89 | 21.30 | 31.10 | 29.68 | |
| Short Term Provisions | 0.16 | 0.08 | 6.48 | 41.00 | 5.80 | |
| Total Current Liabilities | 169.51 | 151.85 | 125.94 | 129.62 | 78.15 | |
| Total Capital And Liabilities | 450.72 | 397.57 | 356.58 | 342.68 | 168.78 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 142.76 | 138.18 | 119.57 | 90.77 | 58.41 | |
| Intangible Assets | 1.71 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 0.00 | 0.00 | 14.29 | 12.15 | 0.00 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 144.47 | 138.18 | 133.87 | 102.92 | 58.41 | |
| Non-Current Investments | 3.55 | 3.55 | 3.55 | 4.33 | 4.28 | |
| Deferred Tax Assets [Net] | 1.61 | 0.03 | 0.00 | 0.00 | 0.04 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 8.11 | 0.17 | |
| Other Non-Current Assets | 16.19 | 12.44 | 11.64 | 0.00 | 0.00 | |
| Total Non-Current Assets | 165.82 | 154.19 | 149.06 | 115.36 | 62.90 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 4.44 | |
| Inventories | 83.47 | 78.39 | 86.31 | 53.36 | 17.36 | |
| Trade Receivables | 155.90 | 115.98 | 73.29 | 70.71 | 37.78 | |
| Cash And Cash Equivalents | 14.29 | 5.04 | 6.09 | 10.87 | 5.13 | |
| Short Term Loans And Advances | 0.00 | 16.39 | 10.35 | 92.38 | 41.17 | |
| OtherCurrentAssets | 31.25 | 27.58 | 31.48 | 0.00 | 0.00 | |
| Total Current Assets | 284.90 | 243.38 | 207.52 | 227.32 | 105.88 | |
| Total Assets | 450.72 | 397.57 | 356.58 | 342.68 | 168.78 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 36.98 | 0.35 | 0.51 | 0.05 | 0.59 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 21.52 | 20.06 | 18.78 | 65.11 | 29.41 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 2.24 | 1.13 | 9.92 | 7.17 | 1.28 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | 195.44 | 138.34 | 119.77 | 299.72 | 165.77 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 5.68 | 5.68 | 5.68 | 5.68 | 5.68 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 3.55 | 3.55 | 3.55 | 4.33 | 4.28 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | 4.44 |
08.09.2025
Kwality Pharmac Standalone June 2025 Net Sales at Rs 111.48 crore, up 39.21% Y-o-Y
20.05.2025
Kwality Pharmac Consolidated March 2025 Net Sales at Rs 115.68 crore, up 25.77% Y-o-Y
20.05.2025
Kwality Pharmac Standalone March 2025 Net Sales at Rs 115.68 crore, up 25.77% Y-o-Y
01.02.2025
Kwality Pharmac Consolidated December 2024 Net Sales at Rs 84.41 crore, up 8.08% Y-o-Y
08.09.2025
Kwality Pharmac Standalone June 2025 Net Sales at Rs 111.48 crore, up 39.21% Y-o-Y
20.05.2025
Kwality Pharmac Consolidated March 2025 Net Sales at Rs 115.68 crore, up 25.77% Y-o-Y
20.05.2025
Kwality Pharmac Standalone March 2025 Net Sales at Rs 115.68 crore, up 25.77% Y-o-Y
01.02.2025
Kwality Pharmac Consolidated December 2024 Net Sales at Rs 84.41 crore, up 8.08% Y-o-Y